Delivery Order SPE2DB22D2007-SPE2DB24FJ6BG

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $22,446.47 and is a firm-fixed-price delivery order. The ultimate completion date for this order is September 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $13,959.26 and a completion date of September 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for the delivery of a comprehensive range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $18,823.96 and an ultimate completion date of October 9, 2024. The contract is a Firm Fixed Price arrangement and is not set aside for any specific business designation. This award is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has a ceiling value of $9,067.61 and a period of performance through April 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication, and has a firm fixed price ceiling value of $9,063.60. The contract has an ultimate completion date of January 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $9,432.18 and a completion date of April 10, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $13,995.73 and an ultimate completion date of May 1, 2023. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication. The order has a ceiling value of $1,911.04 and a completion date of December 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has an ultimate completion date of August 28, 2024 and a ceiling value of $1,847.20. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $1,888.25 and a completion date of April 4, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ6BG
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The order has a ceiling value of $1,847.20 and a completion date of September 12, 2024. The contract is a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and other pharmaceutical products, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/11/24, 9:35 AM